The Concept of in Vitro Diagnosis
- 1270.908
- -9.606-0.75%
Keqian Biology (688526): A leader in developing innovative non-strong immune vaccines focuses on industry recovery and new product promotion
Jiuqiang Biotech (300406): Sinopharm's investment plan to continue to increase the IVD platform is beginning to take shape
Jiuqiang Biotech (300406): Sinopharm empowers the steady development of established IVD companies to reduce costs and increase efficiency
Jiuqiang Biotech (300406): Sinopharm's shareholding ratio continues to increase, demonstrating confidence in the company's development and recognition of value
Major bank rating: CMB International: bullish on innovative drugs and leading medical device companies with high growth in medical consumer stocks due to attractive valuations in the pharmaceutical industry.
Renfu Pharmaceutical (600079): Scenario breakthroughs, innovative breakthroughs open up space for narcotics growth
Research reports | China Post Securities: Shanghai Raas Blood Products' equity transfer officially landed, and the company embarked on a new journey.
Shanghai Rice (002252): Equity transfer officially landed at Haier to enable long-term development
Mindray Healthcare (300760) Company Information Update Report: Implementation of the overall solution for high consumption+equipment and the development of digital intelligence can be expected
Mindray Healthcare (300760): Mindray Healthcare's High ROE and Undervaluation Thinking
Mindray Healthcare (300760): Steady growth in performance, continued breakthroughs for high-end overseas customers
Gongdong Medical (605369): The performance of high-score medical suppliers will return to rapid growth
Pumen Technology (688389): Rehabilitation Medicine and Aesthetic+IVD Dual Drive Becoming a Platform Device Company
Sannuo Biology (300298): CGM has great potential
Sannuo Biotech (300298): Quarterly profit slightly exceeded expectations and is optimistic about CGM's continued volume
Antu Biotech (603658): The 24Q1 profit growth rate exceeded expectations, and the regular business grew steadily
Pumen Technology (688389): IVD and Treatment and Rehabilitation Qifei Device Platform Company Starts
Shantao Environmental Energy (000803): High costs suppress performance and wait for targeted increases to be implemented
Gongdong Medical (605369): Short-term 2023 results are under pressure, and the pace of internationalization is accelerating
Dirui Medical (300396): Continued optimization of China Resources's main product structure